Charlie Bryant

Charlie Bryant has a diverse work experience, starting with their role as a Co-founder at Simple Pharma in November 2019. Charlie then went on to co-found Androlabs in May 2022. Prior to that, Charlie was involved in the establishment of Theramex, a pharmaceutical company focused on women's health. At Theramex, they played a role in building the company's infrastructure from scratch. Charlie was also a part of Entrepreneur First's EF10 Cohort in 2018, where they were exposed to Europe's top talent investor. Before that, they worked as an Operations Strategy Lead at Brisqq, overseeing improvements in gross margin and leading the company's expansion into Amsterdam. Charlie began their career as an intern at J.P. Morgan in 2013. Charlie's experience also includes working at Strategy& (formerly Booz & Company), where they held roles as a Senior Associate and an Associate.

Charlie Bryant attended Hampton School for their early education. Later, they went on to study at the University of Oxford, where they pursued a degree in Chemistry (MChem). However, the specific start and end years for their education have not been provided.